Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Report: Manufacturing Mergers Remain Active In First Quarter

By Pharmaceutical Processing | September 2, 2015

Mergers in the manufacturing and distribution industries are off 2014’s pace but remain high relative to recent years, according to a new report. The latest Capital M&A Review & Outlook from accounting firm BDO said that mergers and acquisitions in the first quarter of 2015 declined modestly compared to the same period last year.

The number of closed transactions, however, remained about 10 percent more than the firm’s five-year historical average.

Read more: Manufacturing’s trifecta: Optimism, growth and investment.

The report said that financial buyers — as opposed to strategic buyers — were helped by access to inexpensive debt. Private equity firms, in particular, maintained $535 billion in available equity, the highest level since 2009. BDO said that those firms “are eagerly pursuing acquisition candidates and providing stiff competition for strategic acquirers in M&A auctions.”

The report added that equity firms showed increased flexibility in the structure of acquisitions, which included complete buyouts and minority investments. Private equity exits from the market increased by more than 20 percent last year, which helped fuel a healthy fundraising market.

Equity firms also helped raise the average investment timeframe from 3.4 years in 2008 to a record 5.7 years in 2014 as they took more time to reach desired returns. Although the report said that overall economic data for the U.S. in the first quarter “was not particularly inspiring,” higher transaction volumes during that three-month period should translate to strong numbers for the remainder of 2015.

BDO’s index of manufacturing and distribution stocks, meanwhile, climbed by 80 percent over the last five years amid the economy’s recovery from recession.

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE